Geode Capital Management
VTAK icon

Geode Capital Management’s Catheter Precision VTAK Stock Holding History

Geode Capital Management’s Portfolio VTAK Stock Details VTAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$48.1K Buy
+47,659
New +$80.8K ﹤0.01% 4326
2025
Q3 		– Sell
-2,853
Closed -$13.1K – 4570
2025
Q2 		$13.1K Hold
2,853
– – ﹤0.01% 4409
2025
Q1 		$18.6K Buy
+2,853
New +$21.6K ﹤0.01% 4361
2024
Q2 		– Sell
-155
Closed -$14.3K – 4626
2024
Q1 		$14.3K Hold
155
– – ﹤0.01% 4519
2023
Q4 		$11.9K Hold
155
– – ﹤0.01% 4574
2023
Q3 		$13.1K Buy
155
+86
+125% +$9.99K ﹤0.01% 4691
2023
Q2 		$12.1K Sell
69
-1
-1% -$231 ﹤0.01% 4703
2023
Q1 		$20.4K Sell
70
-1
-1% -$543 ﹤0.01% 4700
2022
Q4 		$79K Buy
71
+63
+788% +$52.2K ﹤0.01% 4475
2022
Q3 		$9K Hold
8
– – ﹤0.01% 4995
2022
Q2 		$23K Buy
8
+4
+100% +$12.4K ﹤0.01% 4904
2022
Q1 		$16K Hold
4
– – ﹤0.01% 4941
2021
Q4 		$65K Hold
4
– – ﹤0.01% 4815
2021
Q3 		$131K Buy
4
+2
+100% +$62.9K ﹤0.01% 4598
2021
Q2 		$64K Hold
2
– – ﹤0.01% 4628
2021
Q1 		$69K Buy
+2
New +$131K ﹤0.01% 4361

Other funds holding VTAK

VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AF
Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return
PUI
Purpose Unlimited Inc Toronto $2.42B AUM
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return

Geode Capital Management's VTAK Position: Q1 2026 in Review

Geode Capital Management opened a new position in Catheter Precision (VTAK) in Q1 2026: 47,659 shares worth $48.1K. The stake represents ﹤0.01% of the portfolio and ranks #4326 among its holdings. This is a return to the name: Geode Capital Management previously reported a position in VTAK as recently as Q2 2025.

Geode Capital Management first reported a position in VTAK in Q1 2021 and has held it in 16 quarters since. The position peaked at $131K in Q3 2021. 12 funds tracked by Wall St. Rank hold VTAK as of Q1 2026.

  • Geode Capital Management held 47,659 shares of Catheter Precision worth $48.1K as of Q1 2026.
  • Catheter Precision was a new Geode Capital Management position in Q1 2026.
  • Catheter Precision made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #4326 holding.
  • Geode Capital Management first reported a position in Catheter Precision in Q1 2021 and has held it in 16 quarters since.
  • Geode Capital Management's Catheter Precision position peaked at $131K in Q3 2021.
  • 12 funds tracked by Wall St. Rank held Catheter Precision as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.